ASCGX
Price
$28.16
Change
-$0.55 (-1.92%)
Updated
Jul 13 closing price
Net Assets
17.62M
VISGX
Price
$98.15
Change
-$1.40 (-1.41%)
Updated
Jul 13 closing price
Net Assets
47.01B
Interact to see
Advertisement

ASCGX vs VISGX

ASCGX vs VISGX Comparison Chart in %
View a ticker or compare two or three
VS
ASCGX vs. VISGX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASCGX is a Hold and VISGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 47B vs. ASCGX (17.6M). VISGX pays higher dividends than ASCGX: VISGX (0.31) vs ASCGX (0.00). ASCGX was incepted earlier than VISGX: ASCGX (22 years) vs VISGX (28 years). ASCGX (3.06) is less costly to investors than VISGX (0.19). ASCGX is a more actively managed with annual turnover of: 358.00 vs. VISGX (24.00). VISGX has a lower initial minimum investment than ASCGX: VISGX (0) vs ASCGX (100). ASCGX annual gain was more profitable for investors over the last year : 41.15 vs. VISGX (26.83). VISGX return over 5 years is better than : 27.48 vs. ASCGX (-11.57).
ASCGXVISGXASCGX / VISGX
Total Expense Ratio3.060.191,611%
Annual Report Gross Expense Ratio3.060.191,611%
Fund Existence22 years28 years-
Gain YTD23.34617.346135%
Front LoadN/AN/A-
Min. Initial Investment1000-
Min. Initial Investment IRAN/AN/A-
Net Assets17.6M47B0%
Annual Yield % from dividends0.000.31-
Returns for 1 year41.1526.83153%
Returns for 3 years65.8451.09129%
Returns for 5 years-11.5727.48-42%
Returns for 10 years67.39180.4437%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POVSX34.06N/A
N/A
Putnam International Equity A
CIVIX25.29N/A
N/A
Causeway International Value Instl
EMEAX18.89N/A
N/A
Ashmore Emerging Markets Equity A
AVEAX18.02N/A
N/A
Ave Maria Growth Focused
BGEVX14.50-0.18
-1.21%
Baillie Gifford International Growth 5